Stoke Therapeutics, Inc
Nasdaq STOK · Bedford, MA
Works in Neurology
Stoke Therapeutics, Inc is a clinical trial sponsor based in Bedford, MA, listed as Nasdaq STOK. It has 2 active clinical trials with 230 planned participants, in Neurology. Since 2021 it has completed 1 trial and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq STOK
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Stoke Therapeutics, Inc
Stoke Therapeutics, Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 230 planned participants, in Neurology. Since 2021 it has completed 1 trial and stopped 0 early.
Stoke Therapeutics, Inc is based in Bedford, MA and is listed as Nasdaq STOK. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Stoke Therapeutics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-08-24.
Approve Suite is not affiliated with Stoke Therapeutics, Inc. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.